Key takeaways

  • Being Rh-negative is not a problem by itself. The risk arises only if your baby is Rh-positive and your immune system makes antibodies against the baby's blood (called sensitisation).
  • Anti-D immunoglobulin prevents sensitisation. The standard plan is one dose (1500 IU / 300 mcg) at 28 weeks, plus another within 72 hours of delivery if the baby is Rh-positive.
  • Anti-D is also needed within 72 hours of any 'sensitising event' — miscarriage, ectopic, abortion (MTP), CVS, amniocentesis, turning a breech baby, abdominal injury, or bleeding in pregnancy.
  • Anti-D works only before you are sensitised. The Indirect Coombs Test (ICT) checks whether antibodies have already formed.
  • It is free at government facilities under JSSK and costs roughly Rs 2,500-5,000 per vial in private. Never skip a dose over cost.
  • ABO incompatibility (mother O, baby A or B) is a different, usually milder condition and has no anti-D equivalent.

What being Rh-negative means for your pregnancy

Your red blood cells either carry a protein called the RhD antigen or they do not. If they do, you are Rh-positive; if they do not, you are Rh-negative. In India, about 93 to 95 percent of people are Rh-positive and only 5 to 7 percent are Rh-negative — a lower rate than in Europe (15 to 17 percent), because the Rh-negative gene is less common in South Asian populations.

Rh-negative status only becomes relevant in pregnancy if your baby is Rh-positive. That can happen when the baby's father is Rh-positive. Since most Indian fathers are Rh-positive, the majority of Rh-negative mothers carry an Rh-positive baby at some point.

Here is the key idea. During pregnancy and especially at delivery, tiny amounts of the baby's blood can cross into your bloodstream. If those cells are Rh-positive and yours are Rh-negative, your immune system may treat them as foreign and start making antibodies against them. This is called sensitisation.

Once you are sensitised, the antibodies stay in your blood for life. They usually do not harm the current baby much, but in a future Rh-positive pregnancy they cross the placenta and attack that baby's red cells. This is haemolytic disease of the fetus and newborn (HDFN), which can range from mild jaundice and anaemia to severe anaemia, heart failure and, in the worst cases, loss of the baby. The whole point of modern Rh care is to stop sensitisation from ever happening.

A few India-specific points worth knowing:

Your blood group and Rh status should be documented at your first antenatal visit, ideally before 12 weeks, as part of routine first-visit blood tests. Knowing the baby's father's blood group also helps — if he is Rh-negative too, the baby cannot be Rh-positive and anti-D is not needed at all.

Antibody screening: the Indirect Coombs Test (ICT)

The Indirect Coombs Test (ICT), also called the indirect antiglobulin test, checks whether you have already developed antibodies against Rh-positive blood. It is done at your first visit and repeated at 28 weeks, just before the antenatal anti-D dose. In private labs it costs roughly Rs 200-500, and it is free at government facilities under JSSK.

A negative ICT means you are not sensitised. This is what most Rh-negative women have, and it is exactly the situation anti-D is designed to protect. You receive anti-D at 28 weeks, again after delivery if the baby is Rh-positive, and after any sensitising event.

A positive ICT means antibodies are already present. At this point anti-D can no longer undo the existing antibodies, so the focus shifts from prevention to watching the baby closely. The lab identifies which antibody it is and measures the titre (its strength, written as a dilution such as 1:16 or 1:32).

In a sensitised pregnancy, the titre is usually checked monthly until 28 weeks and then more often. A titre at or above the 'critical' level (commonly 1:16 to 1:32 for anti-D, depending on the lab) signals real risk to the baby and triggers extra monitoring — most importantly a middle cerebral artery (MCA) Doppler scan, which can detect fetal anaemia without any needle. Your team may also recommend referral to a fetal-medicine centre for closer care.

It is not only anti-D that matters. Screening also picks up other antibodies that can cause HDFN, such as anti-c, anti-E, anti-Kell, anti-Fya and anti-Jka. Anti-Kell deserves a special mention: it can cause severe disease and is poorly predicted by titre alone, so MCA Doppler is relied on more heavily. The honest summary is that Rh-negative care is really about screening for all clinically important red-cell antibodies, then tailoring the plan to whichever one shows up.

The anti-D plan: 28 weeks, after delivery, and the 72-hour rule

Anti-D immunoglobulin is a ready-made antibody given by injection. When an Rh-negative, non-sensitised woman is exposed to Rh-positive cells, the anti-D mops up those cells before her own immune system can react — so no permanent antibodies form. It has cut Rh disease by more than 90 percent wherever it is used routinely. The standard Indian vial is 1500 IU, which is the same as the 300 mcg vials used elsewhere, just written in different units.

The antenatal dose. Every Rh-negative woman with a negative ICT should get anti-D 1500 IU as an injection at 28 weeks. This covers the third trimester, when most silent leaks of fetal blood happen. (Some Western protocols give two doses, at 28 and 34 weeks; the single 28-week dose is the common Indian practice.) A private vial costs about Rs 2,500-5,000; it is free at government facilities under JSSK.

The postpartum dose. After delivery the baby's cord blood is checked. If the baby is Rh-positive, you get anti-D within 72 hours of birth (sooner is better). If the baby is Rh-negative, no postpartum dose is needed. The 72-hour window matters — protection drops sharply after it. If there was a large bleed during delivery, a Kleihauer-Betke test measures how much fetal blood crossed over, and a bigger anti-D dose may be given.

The 72-hour rule for sensitising events. Beyond the routine doses, anti-D is needed within 72 hours of anything that could leak fetal blood into your circulation. This is the rule most women have not heard of, and the one that prevents the most avoidable sensitisation. Each of the events below counts. The principle is simple: in an Rh-negative woman, any pregnancy bleed, procedure or injury deserves anti-D — the cost of one extra dose is far smaller than the cost of missing one.

ABO incompatibility: a different, usually milder condition

ABO incompatibility is often confused with Rh disease, but it is separate and usually much milder. It happens when the mother is blood group O and the baby is A, B or AB. Group O mothers naturally carry anti-A and anti-B antibodies from early childhood (formed in response to common gut bacteria and food, not pregnancy). Most of these are the IgM type, which cannot cross the placenta, but a small fraction is IgG, which can — and this can cause mild haemolysis in the baby.

The differences from Rh disease are important and mostly reassuring:

Because the antibodies are natural, there is no anti-D-style injection to prevent ABO incompatibility — and none is usually needed. It is picked up after birth if the baby develops jaundice in the first day or two, confirmed with a cord-blood Coombs test and bilirubin level. Treatment is the standard approach to newborn jaundice: phototherapy, good feeding, and watching the bilirubin trend. Severe cases occasionally need IVIG or an exchange transfusion, but most babies recover within one to two weeks with an excellent outcome.

An Rh-negative mother can be ABO-incompatible too. Interestingly, ABO incompatibility offers a little natural protection against Rh sensitisation, because the mother's anti-A or anti-B clears stray fetal cells quickly. That protection is partial, though — anti-D is still given on the usual schedule regardless of ABO status.

When you are already sensitised: monitoring the baby

If antibodies have already formed (ICT positive), the plan changes from prevention to careful surveillance of the baby. Anti-D can no longer help the current pregnancy, so the aim is to detect and treat fetal anaemia early. Care for a sensitised pregnancy is best led by a fetal-medicine specialist.

First, your team works out whether the baby is even at risk. If the father is Rh-negative, the baby is Rh-negative and no further action is needed. If he is Rh-positive, knowing whether he carries one or two copies of the Rh-positive gene helps estimate the chance the baby is affected. A blood test that reads the baby's own DNA from the mother's blood (cell-free fetal DNA, the same technology behind NIPT) can confirm the baby's Rh type non-invasively from about 10-12 weeks.

The key monitoring tool is the MCA Doppler scan. An anaemic baby speeds up blood flow in a brain artery (the middle cerebral artery) to protect the brain, and ultrasound can measure this. A value above 1.5 multiples of the median (MoM) suggests significant anaemia and prompts action. MCA Doppler is part of the wider toolkit of fetal Doppler surveillance used in high-risk pregnancies, and it is offered at fetal-medicine units such as AIIMS centres, KEM Mumbai and CMC Vellore.

When the scan confirms moderate to severe anaemia, the treatment is an intrauterine transfusion (IUT) — giving the baby compatible (O-negative) blood through a fine ultrasound-guided needle into the umbilical vein, usually repeated every two to four weeks until about 32-34 weeks. Delivery is then planned for around 35-37 weeks at a centre equipped to manage a newborn with HDFN. IUT is a specialised procedure carried out only at tertiary fetal-medicine centres; in private settings it can cost roughly Rs 50,000 to 1.5 lakh per procedure, and it is provided free at government tertiary centres under JSSK.

If the baby is born with HDFN: jaundice, anaemia and treatment

A baby affected by HDFN may show jaundice and anaemia soon after birth. Jaundice from HDFN typically appears within the first 24 hours, which is what distinguishes it from ordinary physiological jaundice that shows up on day 2 or 3. Most babies do very well with timely treatment.

At birth, the cord blood is checked for the baby's Rh group, a direct Coombs test (DCT), haemoglobin and bilirubin. Bilirubin and haemoglobin are then repeated at intervals, with bilirubin plotted on an age-based chart (such as the Bhutani nomogram) to decide when treatment is needed.

Treatment is matched to severity:

For most babies the outlook is excellent. After more severe disease, a small number need iron and folic acid for a few weeks for ongoing or 'late' anaemia, and occasionally a top-up transfusion. The serious complication everyone is working to avoid is kernicterus — brain injury from very high bilirubin — which is why early monitoring and prompt phototherapy matter so much. For the full picture on bilirubin thresholds and timing, see our detailed guide to newborn jaundice in India.

Cost, access and government schemes

Anti-D is on the WHO Essential Medicines List and India's National List of Essential Medicines. In private pharmacies a 1500 IU vial costs about Rs 2,500-5,000 depending on brand (Rhoclone, Rhophylac, WinRho and others). For a typical Rh-negative woman with an Rh-positive baby, the antenatal plus postpartum doses come to roughly Rs 5,000-10,000, with extra doses if there is a sensitising event.

Under JSSK (Janani Shishu Suraksha Karyakram), anti-D and the related blood tests are free at government facilities for Rh-negative women — both the 28-week dose and the postpartum dose. Major government hospitals and medical colleges usually keep it in stock, but smaller PHCs and CHCs can run short. If you plan to deliver at a government facility, it is worth confirming anti-D is available in advance, with a backup plan to source it from a higher centre or a pharmacy within the 72-hour window.

Other schemes also cover Rh care. PMJAY (Ayushman Bharat) covers comprehensive maternity care, including intrauterine transfusion and NICU treatment, at empanelled hospitals. PMSMA offers a free specialist antenatal review each month. Many states run their own schemes, and CGHS, ESI and most private insurers cover anti-D as a medical necessity.

Two practical reminders that prevent most failures. First, carry a card (or wear a medical-alert bracelet) noting that you are Rh-negative — this matters if you are ever in an accident and need a transfusion, as you must receive Rh-negative blood. Second, if you are discharged early after delivery, make sure the postpartum anti-D is given before you leave or that there is a firm plan to receive it within 72 hours. The bottom line: in India, Rh care is genuinely affordable through one route or another, so no one should ever delay anti-D because of cost.

When to see a doctor

If you know you are Rh-negative, do not wait for a routine appointment if any of the following happen — each one may need anti-D within 72 hours, or closer monitoring of your baby.

If you do not yet know your blood group and you are pregnant or planning a pregnancy, ask for it to be checked at your first visit. It is a standard, inexpensive test, and knowing your Rh status early is the single most useful step you can take.

Planning your next pregnancy

What happens in this pregnancy shapes the next one. If you stayed non-sensitised (a negative ICT at the end of pregnancy, with anti-D given correctly), the standard plan simply repeats next time. If you became sensitised, future Rh-positive pregnancies need specialised care from the start.

If you are not sensitised, the plan for the next pregnancy is the familiar one: confirm your Rh status and a negative ICT at the first visit, check the baby's father's blood group if not already known, then anti-D at 28 weeks, within 72 hours of delivery if the baby is Rh-positive, and after any sensitising event. A healthy gap of about 18-24 months between pregnancies is sensible for general recovery, and this is a good time to start folic acid before conception.

If you are sensitised, it is worth understanding that the antibodies are permanent and will affect any future Rh-positive baby, often more than the last. Pre-conception counselling with a fetal-medicine specialist helps you plan realistically: confirming the father's Rh genotype, reviewing what happened last time, and arranging early referral, titre monitoring and MCA Doppler in the next pregnancy. Some couples also seek genetic counselling to think through the options ahead.

Finally, the emotional side is real. Managing a sensitised pregnancy can be stressful, and a previous loss makes the next pregnancy anxious. Ask for support — from your team, and from counselling where it helps. Outcomes for sensitised pregnancies have improved enormously with modern fetal medicine, and most women go on to have healthy babies with the right care.

Myths about Rh-negative pregnancy, corrected

Myth: the anti-D injection harms the baby

  • False. Anti-D has been used safely in millions of pregnancies for over 50 years. It works by clearing stray fetal red cells from the mother's blood before her immune system reacts. The small amount that crosses the placenta does not harm the baby.
  • The known downsides are minor — mild soreness at the injection site, very rare allergic reactions, and a negligible risk from a plasma-derived product (modern screening makes this extremely small). The benefit, preventing serious disease in future babies, vastly outweighs this. Refusing anti-D over unfounded fears puts your future pregnancies at real risk.

Fact: anti-D is needed after any sensitising event, not just at 28 weeks and after birth

  • Many women know about the 28-week and postpartum doses but not the 72-hour rule. Anti-D is also needed within 72 hours of a miscarriage, ectopic, abortion (MTP), CVS, amniocentesis, ECV for breech, abdominal injury, bleeding in pregnancy, or stillbirth.
  • Each of these can leak fetal blood into your circulation. Do not assume an event is 'too minor' for anti-D — any pregnancy bleed, procedure or injury in an Rh-negative woman should prompt a dose within the window. When in doubt, ask.

Myth: my first Rh-positive baby was fine, so the next will be too

  • This belief is dangerous. The first sensitised pregnancy is often mild because antibodies are still building. If you were sensitised at that first delivery (for example, if postpartum anti-D was missed), the next Rh-positive baby could be severely affected.
  • That is why every Rh-negative pregnancy needs an ICT at the first visit, whatever happened before. A negative test means the standard prophylaxis plan; a positive test means closer monitoring and specialist referral.

Fact: ABO incompatibility is different from Rh disease and usually milder

  • ABO incompatibility (mother O, baby A or B) is a separate, usually mild condition causing newborn jaundice that responds to phototherapy. It can affect a first baby and does not predictably worsen with each pregnancy.
  • There is no anti-D equivalent for ABO, and none is needed — the management is detection and jaundice treatment after birth. ABO incompatibility does not replace the need for anti-D in an Rh-negative mother; both can occur, and each is managed on its own.

Frequently asked questions

I am Rh-negative and my husband is Rh-positive. Will my baby definitely be affected?

Not necessarily. The baby may be Rh-positive or Rh-negative depending on the genes inherited from the father. Even if the baby is Rh-positive, anti-D given on schedule almost always prevents any problem in a non-sensitised mother. The risk only materialises if you become sensitised and nothing is done — which the anti-D plan is designed to avoid.

What is the 72-hour rule?

It means anti-D should be given within 72 hours of any event that could leak the baby's blood into yours — delivery of an Rh-positive baby, miscarriage, ectopic, abortion, CVS, amniocentesis, turning a breech baby, abdominal injury or bleeding in pregnancy. Protection is strongest within this window, so do not delay seeking care.

Is anti-D free in India?

Yes, at government facilities under JSSK, along with the blood tests, for Rh-negative women. In private settings a vial costs about Rs 2,500-5,000. PMJAY and most insurers also cover it. Cost should never be a reason to skip a dose — if affordability is a problem, government facilities provide it free.

Does the anti-D injection have side effects for me or my baby?

Side effects are minimal — usually just mild soreness where the injection is given. Serious reactions are rare, and the small amount that reaches the baby does not cause harm. It is one of the best-studied and safest injections in pregnancy care.

I had anti-D in my last pregnancy. Do I need it again?

Yes. Anti-D protects only the pregnancy in which it is given; it does not provide lasting immunity. Every Rh-positive pregnancy needs the full plan again — 28 weeks, after delivery, and after any sensitising event — provided your antibody screen (ICT) is negative.

Is ABO incompatibility as serious as Rh disease?

Usually no. ABO incompatibility (mother O, baby A or B) tends to cause only mild newborn jaundice that responds to phototherapy. Severe disease is uncommon. Unlike Rh disease, it has no preventive injection and does not predictably worsen in later pregnancies.

Sources